|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yu Q, Zhang X, Ji C, Yang H, Gao M, Hong S
and Hu G: Survival analysis of laryngeal carcinoma without
laryngectomy, radiotherapy, or chemotherapy. Eur Arch
Otorhinolaryngol. 269:2103–2109. 2012. View Article : Google Scholar
|
|
3
|
Groome PA, O’Sullivan B, Irish JC,
Rothwell DM, Schulze K, Warde PR, Schneider KM, Mackenzie RG,
Hodson DI, Hammond JA, et al: Management and outcome differences in
supraglottic cancer between Ontario, Canada, and the Surveillance,
Epidemiology, and End Results areas of the United States. J Clin
Oncol. 21:496–505. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kaikkonen MU and Adelman K: Emerging roles
of non-coding RNA transcription. Trends Biochem Sci. 43:654–667.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F,
et al: Landscape of transcription in human cells. Nature.
489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mou K, Liu B, Ding M, Mu X, Han D, Zhou Y
and Wang LJ: lncRNA-ATB functions as a competing endogenous RNA to
promote YAP1 by sponging miR-590-5p in malignant melanoma. Int J
Oncol. 53:1094–1104. 2018.PubMed/NCBI
|
|
8
|
Li X, Zhao X, Yang B, Li Y, Liu T, Pang L,
Fan Z, Ma W, Liu Z and Li Z: Long non-coding RNA HOXD-AS1 promotes
tumor progression and predicts poor prognosis in colorectal cancer.
Int J Oncol. 53:21–32. 2018.PubMed/NCBI
|
|
9
|
Qu Wu T, He L, Tian G, Li L, Zhou L, Jin
H, Ren Q, Wang J, Wang YJ, et al: Regulation of laryngeal squamous
cell cancer progression by the lncRNA H19/miR-148a-3p/DNMT1 axis.
Oncotarget. 7:11553–11566. 2016.PubMed/NCBI
|
|
10
|
Zheng J, Xiao X, Wu C, Huang J, Zhang Y,
Xie M, Zhang M and Zhou L: The role of long non-coding RNA HOTAIR
in the progression and development of laryngeal squamous cell
carcinoma interacting with EZH2. Acta Otolaryngol. 137:90–98. 2017.
View Article : Google Scholar
|
|
11
|
Li D, Feng J, Wu T, Wang Y, Sun Y, Ren J
and Liu M: Long intergenic noncoding RNA HOTAIR is overexpressed
and regulates PTEN methylation in laryngeal squamous cell
carcinoma. Am J Pathol. 182:64–70. 2013. View Article : Google Scholar
|
|
12
|
Wang P, Wu T, Zhou H, Jin Q, He G, Yu H,
Xuan L, Wang X, Tian L, Sun Y, et al: Long noncoding RNA NEAT1
promotes laryngeal squamous cell cancer through regulating
miR-107/CDK6 pathway. J Exp Clin Cancer Res. 35:222016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Z, Wang X, Cao S, Han X, Wang Z,
Zhao X, Liu X, Li G, Pan X and Lei D: The long noncoding RNA TUG1
promotes laryngeal cancer proliferation and migration. Cell Physiol
Biochem. 49:2511–2520. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dhir A, Dhir S, Proudfoot NJ and Jopling
CL: Microprocessor mediates transcriptional termination of long
noncoding RNA transcripts hosting microRNAs. Nat Struct Mol Biol.
22:319–327. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao Lu Y, Liu X, Li Q, Graves-Deal C, Cao
R, Singh Z, Franklin B, Wang JL, Hu JH, et al: lncRNA
MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance
via Wnt/beta-catenin signaling. Nat Med. 23:1331–1341. 2017.
View Article : Google Scholar
|
|
16
|
Cai P, Li H, Huo W, Zhu H, Xu C, Zang R,
Lv W, Xia Y and Tang W: Aberrant expression of LncRNA-MIR31HG
regulates cell migration and proliferation by affecting miR-31 and
miR-31* in Hirschsprung’s disease. J Cell Biochem. 119:8195–8203.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Wu X, Yu Y, Nie T, Hu E, Wu Q, Zhi W,
Jiang T, Wang K, Lu XX, et al: Blocking MIR155HG/miR-155 axis
inhibits mesenchymal transition in glioma. Neuro Oncol.
19:1195–1205. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Miyazono K, Ehata S and Koinuma D:
Tumor-promoting functions of transforming growth factor-β in
progression of cancer. Ups J Med Sci. 117:143–152. 2012. View Article : Google Scholar :
|
|
19
|
Tian L, Li M, Ge J, Guo Y, Sun Y, Liu M
and Xiao H: MiR-203 is downregulated in laryngeal squamous cell
carcinoma and can suppress proliferation and induce apoptosis of
tumours. Tumour Biol. 35:5953–5963. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang B, Lv K, Chen W, Zhao J, Luo J, Wu J,
Li Z, Qin H, Wong TS, Yang W, et al: miR-375 and miR-205 regulate
the invasion and migration of laryngeal squamous cell carcinoma
synergistically via AKT-mediated EMT. Biomed Res Int.
2016:96527892016. View Article : Google Scholar
|
|
21
|
Luo H, Jiang Y, Ma S, Chang H, Yi C, Cao
H, Gao Y, Guo H, Hou J, Yan J, et al: EZH2 promotes invasion and
metastasis of laryngeal squamous cells carcinoma via
epithelial-mesen-chymal transition through H3K27me3. Biochem
Biophys Res Commun. 479:253–259. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tong X, Li L, Li X, Heng L, Zhong L, Su X,
Rong R, Hu S, Liu W, Jia B, et al: SOX10, a novel
HMG-box-containing tumor suppressor, inhibits growth and metastasis
of digestive cancers by suppressing the Wnt/β-catenin pathway.
Oncotarget. 5:10571–10583. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
He P and Jin X: SOX10 induces
epithelial-mesenchymal transition and contributes to nasopharyngeal
carcinoma progression. Biochem Cell Biol. 96:326–331. 2018.
View Article : Google Scholar
|
|
24
|
Tam W, Ben-Yehuda D and Hayward WS: bic, a
novel gene activated by proviral insertions in avian leukosis
virus-induced lymphomas, is likely to function through its
noncoding RNA. Mol Cell Biol. 17:1490–1502. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kluiver J, Poppema S, de Jong D, Blokzijl
T, Harms G, Jacobs S, Kroesen BJ and van den Berg A: BIC and
miR-155 are highly expressed in Hodgkin, primary mediastinal and
diffuse large B cell lymphomas. J Pathol. 207:243–249. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Metzler M, Wilda M, Busch K, Viehmann S
and Borkhardt A: High expression of precursor microRNA-155/BIC RNA
in children with Burkitt lymphoma. Genes Chromosomes Cancer.
39:167–169. 2004. View Article : Google Scholar
|
|
27
|
van den Berg A, Kroesen BJ, Kooistra K, de
Jong D, Briggs J, Blokzijl T, Jacobs S, Kluiver J, Diepstra A,
Maggio E, et al: High expression of B-cell receptor inducible gene
BIC in all subtypes of Hodgkin lymphoma. Genes Chromosomes Cancer.
37:20–28. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Thompson RC, Vardinogiannis I and Gilmore
TD: Identification of an NF-κB p50/p65-responsive site in the human
MIR155HG promoter. BMC Mol Biol. 14:242013. View Article : Google Scholar
|
|
29
|
Vargova K, Curik N, Burda P, Basova P,
Kulvait V, Pospisil V, Savvulidi F, Kokavec J, Necas E, Berkova A,
et al: MYB transcriptionally regulates the miR-155 host gene in
chronic lymphocytic leukemia. Blood. 117:3816–3825. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Elton TS, Selemon H, Elton SM and
Parinandi NL: Regulation of the MIR155 host gene in physiological
and pathological processes. Gene. 532:1–12. 2013. View Article : Google Scholar
|
|
31
|
Qu Y, Zhang H and Sun W: MicroRNA-155
promotes gastric cancer growth and invasion by negatively
regulating transforming growth factor-beta receptor 2. 109:618–628.
2018.
|
|
32
|
Liu J, Chen Z, Xiang J and Gu X:
MicroRNA-155 acts as a tumor suppressor in colorectal cancer by
targeting CTHRC1 in vitro. Oncol Lett. 15:5561–5568.
2018.PubMed/NCBI
|
|
33
|
Lin J, Chen Y, Liu L, Shen A and Zheng W:
MicroRNA-155-5p suppresses the migration and invasion of lung
adenocarcinoma A549 cells by targeting Smad2. Oncol Lett.
16:2444–2452. 2018.PubMed/NCBI
|
|
34
|
Baba O, Hasegawa S, Nagai H, Uchida F,
Yamatoji M, Kanno NI, Yamagata K, Sakai S, Yanagawa T and Bukawa H:
MicroRNA-155-5p is associated with oral squamous cell carcinoma
metastasis and poor prognosis. J Oral Pathol Med. 45:248–55. 2016.
View Article : Google Scholar
|
|
35
|
Kim H, Yang JM, Ahn SH, Jeong WJ, Chung JH
and Paik JH: Potential oncogenic role and prognostic implication of
MicroRNA-155-5p in oral squamous cell carcinoma. Anticancer Res.
38:5193–5200. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhao X, Zhang W and Ji W: YB-1 promotes
laryngeal squamous cell carcinoma progression by inducing miR-155
expression via c-Myb. Future Oncol. 14:1579–1589. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhao XD, Zhang W, Liang HJ and Ji WY:
Overexpression of miR - 155 promotes proliferation and invasion of
human laryngeal squamous cell carcinoma via targeting SOCS1 and
STAT3. PLoS One. 8:e563952013. View Article : Google Scholar
|
|
38
|
Wang JL, Wang X, Yang D and Shi WJ: The
Expression of MicroRNA-155 in plasma and tissue is matched in human
laryngeal squamous cell carcinoma. Yonsei Med J. 57:298–305. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hong CS and Saint-Jeannet JP: Sox proteins
and neural crest development. Semin Cell Dev Biol. 16:694–703.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mokhtarzadeh Khanghahi A, Satarian L, Deng
W, Baharvand H and Javan M: In vivo conversion of astrocytes into
oligodendrocyte lineage cells with transcription factor Sox10;
Promise for myelin repair in multiple sclerosis. PLoS One.
13:e02037852018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhao Y, Liu ZG, Tang J, Zou RF, Chen XY,
Jiang GM, Qiu YF and Wang H: High expression of Sox10 correlates
with tumor aggressiveness and poor prognosis in human
nasopharyngeal carcinoma. OncoTargets Ther. 9:1671–1677. 2016.
View Article : Google Scholar
|
|
42
|
Zhou D, Bai F, Zhang X, Hu M, Zhao G, Zhao
Z and Liu R: SOX10 is a novel oncogene in hepatocellular carcinoma
through Wnt/β-catenin/TCF4 cascade. Tumour Biol. 35:9935–9940.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: Acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ,
Tao QF, Liu F, Pan W, Wang TT, Zhou CC, et al: A long noncoding RNA
activated by TGF-β promotes the invasion-metastasis cascade in
hepato-cellular carcinoma. Cancer Cell. 25:666–681. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lu Z, Li Y, Che Y, Huang J, Sun S, Mao S,
Lei Y, Li N, Sun N and He J: The TGFβ-induced lncRNA TBILA promotes
non-small cell lung cancer progression in vitro and in vivo via
cis-regulating HGAL and activating S100A7/JAB1 signaling. Cancer
Lett. 432:156–168. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hao Y, Yang X, Zhang D, Luo J and Chen R:
Long noncoding RNA LINC01186, regulated by TGF-β/SMAD3, inhibits
migration and invasion through Epithelial-Mesenchymal-Transition in
lung cancer. Gene. 608:1–12. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Johansson J, Berg T, Kurzejamska E, Pang
MF, Tabor V, Jansson M, Roswall P, Pietras K, Sund M, Religa P, et
al: MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from
growth inhibition to epithelial-mesenchymal transition, invasion
and metastasis in breast cancer. Oncogene. 32:5614–5624. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Li DP, Fan J, Wu YJ, Xie YF, Zha JM and
Zhou XM: MiR-155 up-regulated by TGF-β promotes
epithelial-mesenchymal transition, invasion and metastasis of human
hepatocellular carcinoma cells in vitro. Am J Transl Res.
9:2956–2965. 2017.
|
|
49
|
Kong X, Liu F and Gao J: MiR-155 promotes
epithelial-mesenchymal transition in hepatocellular carcinoma cells
through the activation of PI3K/SGK3/β-catenin signaling pathways.
Oncotarget. 7:66051–66060. 2016. View Article : Google Scholar : PubMed/NCBI
|
